All Stories

  1. Dietary Isoflavone Biochanin A Attenuates Aluminium Chloride-Induced Sporadic Alzheimer’s Disease and Associated Neurobehavioral Alterations Through NRF2-HO1 Pathway Activation and NLRP3 Inflammasome Suppression
  2. Quercetin as therapeutic modality for inflammatory diseases: Where we are and where to go?
  3. Protective Effect of Fisetin on Subacute and Chronic Arsenic and Fluoride Co‐Exposure Induced Hepatic, Renal and Cardiac Toxicities in Mice
  4. Role of microbiota-gut-brain axis in epilepsy and possible interventions
  5. Impact of Oxidative Stress and Neuroinflammation on Sarco/Endoplasmic Reticulum Ca2+-ATPase 2b Downregulation and Endoplasmic Reticulum Stress in Temporal Lobe Epilepsy
  6. Nanoformulated fisetin ameliorates Alzheimer's disease via reducing proinflammatory cytokines and activating the NRF2/HO-1 pathway
  7. Harnessing Therapeutic Potentials of Biochanin A in Neurological Disorders: Pharmacokinetic and Pharmacodynamic Overview
  8. Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS/TNF-α-NLRP3 inflammasomes pathway
  9. Introduction to Complex Brain Disorders, Currently Available Therapies, and Their Limitations
  10. Toxicity Issues of Nanoparticles in the Delivery of Phytoconstituents and Cosmeceuticals
  11. Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective
  12. Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
  13. Flavonoids as promising anticancer therapeutics: Contemporary research, nanoantioxidant potential, and future scope
  14. Vitamin E modified polyamidoamine dendrimer for piperine delivery to alleviate Aβ 1–42 induced neurotoxicity in Balb/c mice model
  15. Fisetin attenuates arsenic and fluoride subacute co-exposure induced neurotoxicity via regulating TNF-α mediated activation of NLRP3 inflammasome
  16. Effect of organic solvents on acetylcholinesterase inhibition and enzyme kinetics
  17. The Pharmacological Activity of Garlic (Allium sativum) in Parkinson’s Disease: From Molecular Mechanisms to the Therapeutic Potential
  18. Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research
  19. Hybrid Quantum Dot as Promising Tools for Theranostic Application in Cancer
  20. Bioactive Flavonoids: A comparative overview of the biogenetic and chemical synthesis approach
  21. Optimisation of tacrolimus dose in fast metabolisers by genotyping
  22. Herbal Approaches for the Management of Neurological Disorders
  23. Pathophysiology and Management Approaches for Huntington’s Disease, Multiple Sclerosis, and Other Neurological Disorder
  24. Pathophysiology and Management Approaches for Traumatic Brain Injury
  25. Nanoscale Topical Pharmacotherapy in Management of Psoriasis: Contemporary Research and Scope
  26. Utilization of Nanotechnology to Improve Bone Health in Osteoporosis Exploiting Nigella sativa and Its Active Constituent Thymoquinone
  27. Capillary Electrophoresis
  28. Enzyme-Linked Immunosorbent Assay
  29. Flavonoids and stilbenoids as a promising arsenal for the management of chronic arsenic toxicity
  30. CRISPR‐based point‐of‐care diagnostics incorporating Cas9, Cas12, and Cas13 enzymes advanced for SARS‐CoV‐2 detection
  31. DNA Methylation: A Promising Approach in Management of Alzheimer’s Disease and Other Neurodegenerative Disorders
  32. Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery
  33. Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
  34. Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements
  35. Protective Effect of Monoisoamyl-2, 3-Dimercaptosuccinic Acid against Manganese-induced Neurotoxicity in Rats
  36. PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability
  37. Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
  38. Effect of Early Lockdown in India During the Outbreak of COVID-19: A Comparative Study of USA, Italy and India
  39. Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities
  40. In silico screening of pyridoxine carbamates for Anti-Alzheimer’s activities
  41. Polymer-Lipid Hybrid Systems: Scope of Intravenous-To-Oral Switch in Cancer Chemotherapy
  42. Effect of hesperidin on fluoride‐induced neurobehavioral and biochemical changes in rats
  43. Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives
  44. Curcumin loaded nanoparticles reversed monocrotophos induced motor impairment and memory deficit: Role of oxidative stress and intracellular calcium level
  45. Modulatory Effect of Serotonergic System in Pentylenetetrazole-Induced Seizures and Associated Memory Deficit: Role of 5-HT<sub>1A</sub> and 5-HT<sub>2A/2C</sub>
  46. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review
  47. Rational approaches for toxicological assessments of nanobiomaterials
  48. Oxidative stress and neurobehavioural changes in rats following copper exposure and their response to MiADMSA and d-penicillamine
  49. Impact of chronic low dose exposure of monocrotophos in rat brain: Oxidative/ nitrosative stress, neuronal changes and cholinesterase activity
  50. Relative Safety of Different Antidepressants for Treatment of Depression in Chronic Epileptic Animals Associated with Depression
  51. Chronic 5-HT3 receptor antagonism ameliorates seizures and associated memory deficit in pentylenetetrazole-kindled mice
  52. Anticonvulsant mechanisms of piperine, a piperidine alkaloid
  53. Revealing Medicinal Plants That Are Useful for the Comprehensive Management of Epilepsy and Associated Comorbidities through In Silico Mining of Their Phytochemical Diversity
  54. Comparative behavioral and neurochemical analysis of phenytoin and valproate treatment on epilepsy induced learning and memory deficit: Search for add on therapy
  55. Adjuvant Anticholinesterase Therapy for the Management of Epilepsy‐Induced Memory Deficit: A Critical Pre‐clinical Study
  56. Psychoneurochemical Investigations to Reveal Neurobiology of Memory Deficit in Epilepsy
  57. Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice
  58. Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice
  59. Naturally occurring himachalenes to benzocycloheptene amino vinyl bromide derivatives: as antidepressant molecules
  60. Age dependent learning and memory deficit in Pentylenetetrazol kindled mice
  61. Anticonvulsant activity of Passiflora incarnata: No role of chrysin
  62. Ameliorative Effect of the Cinnamon Oil fromCinnamomum zeylanicumupon Early Stage Diabetic Nephropathy